메뉴 건너뛰기




Volumn 172, Issue 10, 2005, Pages 1315-1316

Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; RISK FACTOR; WEIGHT REDUCTION;

EID: 19744372910     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.050121     Document Type: Note
Times cited : (13)

References (18)
  • 1
    • 19744368235 scopus 로고    scopus 로고
    • Insulin resistance syndrome, body mass index and the risk of ischemic heart disease
    • St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005;172(10):1301-5.
    • (2005) CMAJ , vol.172 , Issue.10 , pp. 1301-1305
    • St.-Pierre, A.C.1    Cantin, B.2    Mauriège, P.3    Bergeron, J.4    Dagenais, G.R.5    Després, J.P.6
  • 2
    • 0026021161 scopus 로고
    • Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
    • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
    • (1991) Diabetes Care , vol.14 , pp. 173-194
    • Defronzo, R.A.1    Ferrannini, E.2
  • 3
    • 0024160877 scopus 로고
    • Banting Lecture 1988. Role of insulin resistance in human disease
    • Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
    • (1988) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1
  • 4
    • 0024391834 scopus 로고
    • The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
    • Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.
    • (1989) Arch Intern Med , vol.149 , pp. 1514-1520
    • Kaplan, N.M.1
  • 5
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 6
    • 0038073017 scopus 로고    scopus 로고
    • Discrimination of health risk by combined body mass index and waist circumference
    • Ardern CI, Katzmarzyk PT, Janssen I, Ross R. Discrimination of health risk by combined body mass index and waist circumference. Obes Res 2003;11:135-42.
    • (2003) Obes Res , vol.11 , pp. 135-142
    • Ardern, C.I.1    Katzmarzyk, P.T.2    Janssen, I.3    Ross, R.4
  • 7
    • 0042665536 scopus 로고    scopus 로고
    • Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
    • Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-9.
    • (2003) Circulation , vol.108 , pp. 414-419
    • Sattar, N.1    Gaw, A.2    Scherbakova, O.3    Ford, I.4    O'Reilly, D.S.5    Haffner, S.M.6
  • 8
    • 0034837376 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality associated with the metabolic syndrome
    • Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
    • (2001) Diabetes Care , vol.24 , pp. 683-689
    • Isomaa, B.1    Almgren, P.2    Tuomi, T.3    Forsen, B.4    Lahti, K.5    Nissen, M.6
  • 9
    • 0036788311 scopus 로고    scopus 로고
    • Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: The atherosclerosis risk in communities study
    • Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 2002;51:3069-76.
    • (2002) Diabetes , vol.51 , pp. 3069-3076
    • Golden, S.H.1    Folsom, A.R.2    Coresh, J.3    Sharrett, A.R.4    Szklo, M.5    Brancati, F.6
  • 10
    • 0037463608 scopus 로고    scopus 로고
    • The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
    • Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
    • (2003) Arch Intern Med , vol.163 , pp. 427-436
    • Park, Y.W.1    Zhu, S.2    Palaniappan, L.3    Heshka, S.4    Carnethon, M.R.5    Heymsfield, S.B.6
  • 12
    • 4544268297 scopus 로고    scopus 로고
    • Duration of overweight and metabolic health risk in American men and women
    • Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol 2004;14:585-91.
    • (2004) Ann Epidemiol , vol.14 , pp. 585-591
    • Janssen, I.1    Katzmarzyk, P.T.2    Ross, R.3
  • 13
    • 0037417237 scopus 로고    scopus 로고
    • Treatment for patients with the metabolic syndrome
    • Ginsberg HN. Treatment for patients with the metabolic syndrome. Am J Cardiol 2003;91:29E-39E.
    • (2003) Am J Cardiol , vol.91
    • Ginsberg, H.N.1
  • 14
    • 0037118660 scopus 로고    scopus 로고
    • AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
    • American Heart Association Science Advisory and Coordinating Committee
    • Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91.
    • (2002) Circulation , vol.106 , pp. 388-391
    • Pearson, T.A.1    Blair, S.N.2    Daniels, S.R.3    Eckel, R.H.4    Fair, J.M.5    Fortmann, S.P.6
  • 16
    • 12844273382 scopus 로고    scopus 로고
    • Metabolic syndrome, obesity, and mortality: Impact of cardiorespiratory fitness
    • Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 2005;28:391-7.
    • (2005) Diabetes Care , vol.28 , pp. 391-397
    • Katzmarzyk, P.T.1    Church, T.S.2    Janssen, I.3    Ross, R.4    Blair, S.N.5
  • 17
    • 0037203479 scopus 로고    scopus 로고
    • Diet composition and the metabolic syndrome: What is the optimal fat intake?
    • Grundy SM, Abate N, Chandalia M. Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med 2002;113(Suppl 9B):25S-29S.
    • (2002) Am J Med , vol.113 , Issue.SUPPL. 9B
    • Grundy, S.M.1    Abate, N.2    Chandalia, M.3
  • 18
    • 0040076240 scopus 로고    scopus 로고
    • The metabolic syndrome: A new focus for lifestyle modification
    • Szapary PO, Hark LA, Burke FM. The metabolic syndrome: a new focus for lifestyle modification. Patient Care 2002;36:75-88.
    • (2002) Patient Care , vol.36 , pp. 75-88


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.